SCHEMBL3047148

SCHEMBL3047148

COc1ccc(N2C(=O)C(=O)c3ccccc32)cc1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.67
CES1 P23141 2/20 0.67
CES2 O00748 1/20 0.67
BCHE P06276 1/20 0.67
GAA P10253 1/20 0.67
NPSR1 Q6W5P4 1/20 0.67
NR1H3 Q13133 1/20 0.57
PGR P06401 1/20 0.54
AOC3 Q16853 2/20 0.53
RAB9A P51151 2/20 0.50
NPC1 O15118 1/20 0.50
PKM P14618 1/20 0.50
MAPT P10636 1/20 0.50
MGLL Q99685 1/20 0.50
CASP3 P42574 2/20 0.49
KDM4E B2RXH2 1/20 0.49
SENP8 Q96LD8 1/20 0.49
SENP7 Q9BQF6 1/20 0.49
SENP6 Q9GZR1 1/20 0.49
MEN1 O00255 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5658435 0.84 ALDH1A1 (0.63) ALDH1A1CES1CES2BCHEGAA
SCHEMBL12096581 0.84 AGTR1 (0.54) ALDH1A1CES1CES2BCHEGAA
SCHEMBL5353595 0.83 KMT2A (0.70) ALDH1A1CES1CES2BCHEGAA
SCHEMBL29506688 0.81 CES1 (0.73) ALDH1A1CES1CES2BCHEGAA
SCHEMBL20721761 0.81 CES1 (0.73) ALDH1A1CES1CES2BCHEGAA
SCHEMBL5351919 0.81 ALDH1A1 (0.58) ALDH1A1CES1CES2BCHEGAA
SCHEMBL9332619 0.81 ALDH1A1 (0.58) ALDH1A1CES1CES2BCHEGAA
SCHEMBL2550387 0.81 NR1H3 (0.81) ALDH1A1NR1H3PGRRAB9ANPC1
SCHEMBL13985405 0.81 CES1 (0.58) ALDH1A1CES1CES2BCHEGAA
Phenyl Isatin SCHEMBL916808 0.81 CES1 (1.00) ALDH1A1CES1CES2BCHEGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3626699-B1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2023-07-12 EP disclosed
CN-108430970-B Bisphenol compound and aromatic polycarbonate 本州化学工业株式会社 2022-03-11 CN disclosed
US-20210198220-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-07-01 US disclosed
US-11001563-B2 SSAO inhibitor SHANDONG DANHONG PHARMACEUTICAL CO LTD (CN) 2021-05-11 US disclosed
US-10759755-B2 Bisphenol compound and aromatic polycarbonate HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2020-09-01 US disclosed
US-20200115352-A1 SSAO INHIBITOR SHANDONG DANHONG PHARMACEUTICAL CO., LTD. 2020-04-16 US disclosed
EP-3626699-A1 SSAO INHIBITOR Shandong Danhong Pharmaceutical Co., Ltd. (CN) 2020-03-25 EP disclosed
US-20190047954-A1 BISPHENOL COMPOUND AND AROMATIC POLYCARBONATE HONSHU CHEMICAL INDUSTRY CO., LTD. (JP) 2019-02-14 US disclosed
EP-1946108-B1 HIGH QUANTUM YIELD ACRIDINIUM COMPOUNDS AND THEIR USES IN IMPROVING ASSAY SENSITIVITY SIEMENS HEALTHCARE DIAGNOSTICS (US) 2014-10-01 EP disclosed
US-7785904-B2 High quantum yield acridinium compounds and their uses in improving assay sensitivity SIEMENS HEALTHCARE DIAGNOSTICS INC. (US) 2010-08-31 US disclosed
US-7097995-B2 Chemiluminescent acridinium compounds and analogues thereof as substrates of hydrolytic enzymes BAYER CORP. (US) 2006-08-29 US disclosed
US-20050221390-A1 High quantum yield acridinium compounds and their uses in improving assay sensitivity BAYER HEALTHCARE LLC (US) 2005-10-06 US disclosed
EP-1203091-B1 CHEMILUMINESCENT SUBSTRATES OF HYDROLYTIC ENZYMES SUCH AS PHOSPHATASES BAYER AG (US) 2005-03-16 EP disclosed
US-20050032147-A1 Chemiluminescent acridinum compounds and analogues thereof as substrates of hydrolytic enzymes BAYER CORPORATION 2005-02-10 US disclosed
US-6783948-B1 USED IN DIAGNOSTIC IMMUNOASSAYS; HAS DISTINCTLY DIFFERENT LIGHT EMISSION CHARACTERISTICS (EMISSION WAVELENGTH, KINETICS, OR QUANTUM YIELD) BAYER CORPORATION 2004-08-31 US disclosed
EP-1203091-A1 CHEMILUMINESCENT SUBSTRATES OF HYDROLYTIC ENZYMES SUCH AS PHOSPHATASES Bayer Corporation (US) 2002-05-08 EP disclosed
WO-2001009372-A1 CHEMILUMINESCENT SUBSTRATES OF HYDROLYTIC ENZYMES SUCH AS PHOSPHATASES BAYER CORPORATION (US) 2001-02-08 WO disclosed
EP-0369344-B1 N-arylation of isatins ABBOTT LAB (US) 1994-04-06 EP disclosed
US-5151518-A N-arylation of isatins ABBOTT LABORATORIES (US) 1992-09-29 US disclosed
EP-0369344-A1 N-arylation of isatins ABBOTT LABORATORIES (US) 1990-05-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11001563-B2 SSAO inhibitor SSB, ASAH2, AOX1 ALDH1A1 177/4885CES1 1117/4885CES2 3087/4885
US-20050032147-A1 Chemiluminescent acridinum compounds and analogues thereof as substrates of hydrolytic enzymes MPO, LPO, PGLS ALDH1A1 118/4885CES1 142/4885CES2 62/4885
US-20210198220-A1 SSAO INHIBITOR SSB, ASAH2, AOX1 ALDH1A1 177/4885CES1 1117/4885CES2 3087/4885
US-10759755-B2 Bisphenol compound and aromatic polycarbonate PAH, INCENP, BMP2 ALDH1A1 2603/4885CES1 3539/4885CES2 1425/4885
US-20200115352-A1 SSAO INHIBITOR SSB, ASAH2, AOX1 ALDH1A1 177/4885CES1 1117/4885CES2 3087/4885
US-20190047954-A1 BISPHENOL COMPOUND AND AROMATIC POLYCARBONATE PAH, INCENP, BMP2 ALDH1A1 2603/4885CES1 3539/4885CES2 1425/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.